A carregar...

Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor–positive early breast cancer in Canada

BACKGROUND: Aromatase inhibitor (ai) therapy has been subjected to numerous cost-effectiveness analyses. However, with most ais having reached the end of patent protection and with maturation of the clinical trials data, a re-analysis of ai cost-effectiveness and a consideration of ai use as part of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Djalalov, S., Beca, J., Amir, E., Krahn, M., Trudeau, M.E., Hoch, J.S.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4399616/
https://ncbi.nlm.nih.gov/pubmed/25908907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.22.2120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!